BIO
$BIO
Bio-Rad Laboratories
Life science research and clinical diagnostics products.
HealthcareSubscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
BIO: Valuation vs. Growth — Bio-Rad Outlook
Bio-Rad ($BIO) shows attractive trailing earnings and a strong balance sheet, but mixed growth signals and a mid-range stock price mean investors should weigh catalysts like Q1 results on April 29.
Apr 6, 2026